Department of Electrical and Biomedical Engineering, University of Nevada Reno, 89557, USA.
Analyst. 2012 Oct 21;137(20):4815-21. doi: 10.1039/c2an35717h.
A dual signal amplification technique was developed for bioassays. The technique consists of zinc-ion release from ZnS nanoparticle labels and enzyme kinetics activated by the released zinc ions as cofactors. In the ion release process, each ZnS nanoparticle label liberates a high number of zinc ions by acidic dissolution. After the ion release, at appropriate pH levels, the released zinc ions are used as cofactors to trigger the enzymatic activity of carbonic anhydrase. The fluorescence produced from the activated enzyme kinetics is measured for bioassay signal quantification. A model bioassay on mouse IgG adopting this technique presents a detection limit around 0.5 pM and a detection range over at least two orders of magnitude. This technique was also successfully applied to the detection of human cardiac troponin I (cTnI) in human serum samples to demonstrate a clinical diagnosis application. The developed immunoassay is capable of distinguishing clinically critical levels of cTnI. This technique possesses a high detection resolution and offers the advantage of straightforward operation (simple preparation of ZnS nanoparticles and no enzyme immobilization).
开发了一种用于生物分析的双重信号放大技术。该技术包括 ZnS 纳米粒子标记物中锌离子的释放以及被释放的锌离子作为辅因子激活的酶动力学。在离子释放过程中,每个 ZnS 纳米粒子标记物通过酸性溶解释放出大量的锌离子。离子释放后,在适当的 pH 值下,释放的锌离子被用作辅因子来触发碳酸酐酶的酶活性。从激活的酶动力学产生的荧光用于生物分析信号定量。采用该技术的小鼠 IgG 的模型生物分析显示检测限约为 0.5 pM,检测范围至少跨越两个数量级。该技术还成功应用于人血清样本中人心肌肌钙蛋白 I(cTnI)的检测,以证明临床诊断应用。所开发的免疫分析能够区分临床关键水平的 cTnI。该技术具有高检测分辨率,并具有操作简单(简单制备 ZnS 纳米粒子,无需酶固定化)的优点。